ArticleMolecular therapy. Methods & clinical development2017

Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI.

Rita Ferla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.